Scientist to Watch

» infectious disease, genetics & genomics and cancer

Most Recent

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

1 Comment

image: Jason Holliday: Tree Tracker

Jason Holliday: Tree Tracker

By | February 1, 2016

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: Weiwei Dang: Epigenetics in Aging

Weiwei Dang: Epigenetics in Aging

By | March 1, 2015

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: Doris Bachtrog: Sex Chromosome Wrangler

Doris Bachtrog: Sex Chromosome Wrangler

By | January 1, 2015

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: Feng Zhang: The Midas of Methods

Feng Zhang: The Midas of Methods

By | August 1, 2014

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: Yoav Gilad: Gene Regulator

Yoav Gilad: Gene Regulator

By | October 1, 2013

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

3 Comments

image: Kartik Chandran: Chemistry Kid

Kartik Chandran: Chemistry Kid

By | September 1, 2012

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: Sohini Ramachandran: Population Tracker

Sohini Ramachandran: Population Tracker

By | June 1, 2012

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

1 Comment

image: David Sabatini: Demystifying mTOR

David Sabatini: Demystifying mTOR

By | March 1, 2012

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech